EW Healthcare Partners https://validator.w3.org/feed/docs/rss2.html EW Healthcare Partners Acquires Germfree Laboratories, Inc. Home About Us Team Serene, LLC Scott Barry Ascend Advanced Therapies – ABL Inc. Further Strengthens Executive Team As It Drives Forward An Ambitious Growth Strategy Portfolio Ryan Conway Jennifer Reiss Fredrik Thorell EW Healthcare Partners Announces the Appointment of Andy Thomson as an Operating Partner Petri Vainio Legal Disclaimer Investment Strategy News Testimonials Pharmaceuticals MedTech Tech-Enabled Services Limited Partners Brooks Andrews Shaunak Parikh Marty Sutter Bryan Morton Evis Hursever Guido J. Neels Andrew J. Thomson Bob White Ron Eastman EyePoint Pharmaceuticals, Inc. William “Bill” A. Hawkins Contact Us Danielle Leavitt Sage Mandel Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility Jeff Himawan Immanuel Thangaraj EUSA Pharma Announces Acquisition of Global Rights to SYLVANT (siltuximab) from Janssen Sciences Ireland UC for $115 Million EW Healthcare Partners Announces the Closing of EW Healthcare Partners Acquisition Fund with Bioventus as the Core Holding EUSA Pharma Receives Positive CHMP Opinion for Tivozanib for First-Line Treatment EUSA Pharma and AVEO Oncology Announce First Commercial Launch of FOTIVDA (tivozanib) Encore Dermatology Grundium Oy Ted Davis to Succeed Amy Tsend as President and CEO of TissueTech EW Healthcare Partners Announces Platform Investment in Enercon Technologies Prem Chockalingam Greg Hill EyePoint Pharmaceuticals Receives FDA Approval of YUTIQ (fluocinolone acetonide intravitreal implant) 0.18 mg Privacy Policy